Euro vs US Dollar

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

TELA TELA Bio Inc

6,28

-0,08 (-1,26%)

Nach Börsenschluss

Zuletzt aktualisiert: 22:00:01

Verzögert um 15 Minuten

Form 3/A - Initial statement of beneficial ownership of securities: [Amend]

TELA Bio (NASDAQ:TELA)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more TELA Bio Charts.

TELA Bio (NASDAQ:TELA)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more TELA Bio Charts.

News TELA Bio Inc

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Freitag 10 Mai 2024 (1 Woche vor) • Edgar (US Regulatory)

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Freitag 10 Mai 2024 (1 Woche vor) • GlobeNewswire Inc.

Form 8-K - Current report
Donnerstag 9 Mai 2024 (1 Woche vor) • Edgar (US Regulatory)

TELA Bio Reports First Quarter 2024 Financial Results
Donnerstag 9 Mai 2024 (1 Woche vor) • GlobeNewswire Inc.

TELA Bio to Announce First Quarter 2024 Financial Results
Donnerstag 25 April 2024 (3 Wochen vor) • GlobeNewswire Inc.

TELA Bio Announces U.S. Commercial Launch of Robotic-Compatible OviTex® IHR – Addressing the Need for a More Natural Repair in Inguinal Hernia Procedures
Montag 15 April 2024 (1 Monat vor) • GlobeNewswire Inc.

TELA Bio Welcomes Acclaimed Surgeon as Vice President of Medical Affairs and Surgeon Strategy
Montag 8 April 2024 (1 Monat vor) • GlobeNewswire Inc.

TELA Bio Achieves Record Fourth Quarter and Full Year 2023 Revenues and Reports Complete Financial Results
Donnerstag 21 März 2024 (2 Monate vor) • GlobeNewswire Inc.

TELA Bio Announces U.S. Commercial Launch of LIQUIFIX™ – the Only FDA-Approved Liquid Adhesive for Internal Use in Hernia Surgery
Donnerstag 21 März 2024 (2 Monate vor) • GlobeNewswire Inc.

MIMEDX Expands Portfolio with Fibrillar Collagen Wound Dressing
Mittwoch 20 März 2024 (2 Monate vor) • GlobeNewswire Inc.

TELA Bio to Announce Fourth Quarter and Full Year 2023 Financial Results
Donnerstag 29 Februar 2024 (3 Monate vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 27 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Weitere TELA Bio Inc News-Artikel

Invesco QQQ Trust Series 1

Deutsche Telekom

Deutsche Telekom (QX)

BNP Paribas (QX)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen